Simulation-based comparison of Biopharmaceutics Classification System and drug structure

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Computational Chemistry

Background:

• The Biopharmaceutics Classification System (BCS) is crucial for drug development, formulation, and pharmacokinetic prediction.
• It classifies drugs based on solubility and permeability.
• Understanding structure-activity relationships is vital for drug design.

Purpose of the Study:

• To investigate the correlation between small molecule structure and their BCS classification using computational methods.
• To identify characteristic structural and functional features associated with specific BCS classes.

Main Methods:

• 411 small molecules were categorized into BCS classes based on existing data.
• Pybel-FP4 molecular fingerprints were generated and analyzed for information gain (IG).
• Support vector machine prediction and dose coefficient analysis were used for verification.

Main Results:

• Specific structural and functional features were identified for BCS classes III and IV.
• Common features include secondary aliphaticamine, Michael acceptor, isothiourea, and sulfonamide sulfonic derivatives.

Conclusions:

• The study successfully correlated molecular fingerprints with BCS classifications.
• This approach can assist in guiding the development and optimization of novel small-molecule drugs.